Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
about
Understanding of molecular mechanisms in natural killer cell therapySynergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding proteinSurvival adjustment of mature dendritic cells by IL-15.Changes in gene expression induced by tienilic Acid and sulfamethoxazole: testing the danger hypothesisDifferential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activityActivation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.Immunotherapy in atopic dermatitis.Regulation of CCL5 expression in smooth muscle cells following arterial injuryFunction of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.IRF7 regulates TLR2-mediated activation of splenic CD11c(hi) dendritic cells.Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury.Role of interleukin-7 in T-cell development from hematopoietic stem cells.Ontogeny and expansion of human natural killer cells: clinical implications.Biology of natural killer cells in cancer and infection.IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.Viruses and the type I interferon antiviral system: induction and evasion.Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neuronsIL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cellsMyelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts.Roles of interferon-regulatory factors in T-helper-cell differentiation.Gene-expression profiling in vaccine therapy and immunotherapy for cancerInterferon regulatory factor 1 and histone H4 acetylation in systemic lupus erythematosus.Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathwaysNK Cell Proliferation Induced by IL-15 Transpresentation Is Negatively Regulated by Inhibitory Receptors.Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells.Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient miceThe pleiotropic functions of interleukin 15: not so interleukin 2-like after all.Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway.Functional subsets of mouse natural killer cells.The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonAn activation-induced IL-15 isoform is a natural antagonist for IL-15 function.Requirement for membrane lymphotoxin in natural killer cell development.Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo.Immunological pathways in virus-induced COPD exacerbations: a role for IL-15.Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity.The characterization of two novel IRF-3 transcripts starting from intron 2 of the wild type of IRF-3.The Transcription Factor Interferon Regulatory Factor-1 (IRF1) Plays a Key Role in the Terminal Effector Pathways of Human Preterm Labor.Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages.
P2860
Q28086976-E47CF52D-C118-49F8-AF83-4FE637BAE0FFQ28288262-3E7F5083-C11F-4855-AFD0-8D3493D3F8FAQ28510429-C4AC38C2-28EF-459B-A52E-4E62C9A65F01Q28578077-4BB8A6FD-AA51-4193-AE7E-87D918BB464CQ28585232-5DE951E6-790B-469F-8905-E696A3F27D4AQ28586849-E19E520D-25E2-4EAA-B312-75AF076E46BAQ33967201-78C6C3F6-2120-4635-BF50-257A313B6843Q34104585-30413825-BC55-43D3-AF2A-AE09E402AC94Q34146505-2B1BDE6B-A05B-48C2-B075-07DDB95DC05EQ34313946-00AD989F-729E-4AC0-B19D-9F785A99B339Q34345575-FE124556-AD7B-4512-9F27-6C2F9474F577Q34401648-6E9C3E7C-7425-49FD-B58D-6717E79F748EQ34483162-15D645F8-F042-4CA6-AD26-4AB81E962894Q34552167-2D288B09-EC94-4D04-A234-F0F6C375A792Q34651546-35489D90-2CB9-43A6-A371-B2E282B4C5ABQ34687192-0A68F1CF-529B-4277-8B5A-425F7A549382Q35027514-6C6C67E0-03DC-47DD-8739-56B7A322AADEQ35133263-D0EF47BE-590A-4221-9E62-86DD40E0A0B2Q35296962-CD7D2A0C-52BE-4427-88E3-34CA5AC83573Q35578758-5B83A379-188B-40D4-A342-0DEB7839C5FAQ35912886-3C7F28EB-E601-4F3C-A6FD-DA792A6C3E87Q36028191-E04102A2-1E48-49D4-9F26-660ACE715C57Q36138329-E0D0421B-1CDC-4DA5-ADA1-F49974BE3F27Q36214319-303B0572-E553-4DEE-9B3D-37EC1347BD4CQ36228914-CD02A8B9-B87C-4737-9B69-56908DBE92BAQ36260218-64E010F0-3A54-4441-BBC2-D9014B1F00F4Q36368677-E54E7157-B218-4579-9B34-CFD0B20B6484Q36370673-19583150-1C37-4D08-87F6-80169D03D081Q36375999-69D6F112-763A-458B-9B60-3E39DFA8FF20Q36533359-075B3757-226D-4597-92C0-538FAB1DD2F2Q36652157-94286EB5-7F95-4C18-B181-FDA372896F1DQ36682298-D20F56CB-F70A-4D76-BE53-593B68699D15Q36889948-7E8BBD32-58C8-4553-AE36-C844BA0520ACQ37206961-091D0E61-E1A7-451D-9FCC-9C9FDB6F77FCQ37571494-39102951-7E01-4A6B-8D85-DC5A87D737E2Q38001050-C7686D41-FF2C-4E11-92F0-F85776800FBFQ38161582-5DBE76A8-90B3-491F-A0B9-1EB3D1CD14ACQ39625449-1BEBB480-3877-486D-9C5C-F5966F5ED806Q40204740-58900C82-CA06-4FDA-992F-F8E15EF473BCQ40429375-034F88D7-19D1-49E6-A466-667DCE264405
P2860
Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в лютому 1998
@uk
name
Requirement for IRF-1 in the m ...... opment of natural killer cells
@en
Requirement for IRF-1 in the m ...... opment of natural killer cells
@nl
type
label
Requirement for IRF-1 in the m ...... opment of natural killer cells
@en
Requirement for IRF-1 in the m ...... opment of natural killer cells
@nl
prefLabel
Requirement for IRF-1 in the m ...... opment of natural killer cells
@en
Requirement for IRF-1 in the m ...... opment of natural killer cells
@nl
P2093
P2860
P356
P1433
P1476
Requirement for IRF-1 in the m ...... opment of natural killer cells
@en
P2093
Ogasawara K
Taniguchi T
Waldmann TA
Yokochi-Fukuda T
P2860
P2888
P304
P356
10.1038/35636
P407
P577
1998-02-01T00:00:00Z
P6179
1034473167